Saurav Chemicals Limited is a pharmaceutical manufacturing company founded in 1993. The company specializes in producing APIs and advanced intermediates, offering contract manufacturing services to a diverse range of customers, including Lupin Limited, Covalent Laboratories Private Limited, Mitsubishi Corporation India Private Limited, Pharmathen S.A., and Eisai Pharmaceuticals India Private Limited. Headquartered in Panchkula, India, the company operates two manufacturing facilities in Derabassi, Mohali, and conducts marketing from divisions in New Delhi and Mumbai.
The company's commitment to quality is underscored by its strict adherence to European Union Good Manufacturing Practices (EU-GMP), United States Food and Drug Administration (USFDA), and Japanese Pharmaceutical and Medical Devices Agency (JPMDA) norms. Saurav Chemicals Limited places a strong emphasis on compliance, customer partnership, transparency, cost-effective solutions, and achieving results. As of now, there is no publicly available information on the company's last investment or its investors.
There is no investment information
No recent news or press coverage available for Saurav Chemicals Limited.